|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Professional Graduate School of Oriental Medicine
2 Korea Institute of Oriental Medicine
* To whom correspondence should be addressed. E-mail: shrons{at}wonkwang.ac.kr.
| Abstract |
|---|
In this study, we aimed to investigate whether an aqueous extract of Buddleja officinalis (ABO) suppresses high glucose-induced vascular inflammatory process in the primary cultured human umbilical vein endothelial cells (HUVEC). The increase of cell adhesion molecules (CAMs) expression such ICAM-1, VCAM-1, and E-selectin by high glucose was significantly attenuated by pretreatment with ABO in a dose-dependent manner. Enhanced cell adhesion by high glucose in co-cultured U937 and HUVEC induced was also blocked by pretreatment with ABO. Pretreatment with ABO blocked high glucose-induced ROS formation. In addition, ABO suppressed the transcriptional activity of NF-
B and I-
B phosphorylation under high glucose condition. Pretreatment with N(G)-nitro-L-arginine methyl ester (L-NAME), an endothelial NO inhibitor, attenuated the protective action of ABO on high glucose-induced CAMs expression, suggesting a potential role of NO signaling. The present data suggested that ABO could suppress high glucose-induced vascular inflammatory process, which may be closely related with the inhibition of ROS and NF-
B activation in HUVEC.
Key Words:
Buddleja officinalis, Adhesion molecules, ROS, NF-
B, HUVEC
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |